NASDAQ:IART

Integra Lifesciences Holdings Stock News

etoro logo Buy IART
*Your capital is at risk
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra's (IART) first-quarter 2020 results reflect disappointing segmental performance due to coronavirus-led business disruptions.
IART earnings call for the period ending March 31, 2020.
Q1 2020 Integra Lifesciences Holdings Corp Earnings Call
Integra (IART) delivered earnings and revenue surprises of -20.00% and 0.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
PRINCETON, N.J., May 07, 2020 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
The "China Catheters Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abiomed (ABMD), Amgen (AMGN) and Baxter International
The "US Catheters Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
ARP Americas LP purchased a new position in Integra Lifesciences Holdings Corp (NASDAQ:IART) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE